AlphaCore Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
13,935
+2,061
+17% +$166K 0.02% 420
2026
Q1
$840K Sell
11,874
-1,979
-14% -$148K 0.02% 425
2025
Q4
$1.09M Buy
13,853
+8,447
+156% +$669K 0.02% 399
2025
Q3
$445K Buy
5,406
+1,759
+48% +$138K 0.02% 481
2025
Q2
$293K Buy
3,647
+187
+5% +$14.4K 0.01% 491
2025
Q1
$278K Sell
3,460
-4
-0.1% -$333 0.02% 375
2024
Q4
$284K Sell
3,464
-597
-15% -$49.7K 0.06% 178
2024
Q3
$335K Sell
4,061
-70
-2% -$5.23K 0.08% 155
2024
Q2
$290K Buy
+4,131
New +$295K 0.07% 159
2020
Q2
Sell
-121
Closed -$4K 210
2020
Q1
$4K Buy
+121
New +$5.37K ﹤0.01% 269

Other funds holding MET

AlphaCore Capital's MET Position: Q2 2026 in Review

AlphaCore Capital increased its MetLife (MET) stake by 17% in Q2 2026, buying an estimated $166K and bringing the position to 13,935 shares worth $1.18M. The position accounts for 0.02% of the portfolio, ranked #420.

AlphaCore Capital first reported a position in MET in Q1 2020 and has held it in 10 quarters since. 1,440 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • AlphaCore Capital held 13,935 shares of MetLife worth $1.18M as of Q2 2026.
  • AlphaCore Capital bought 2,061 MetLife shares in Q2 2026, an estimated $166K.
  • MetLife made up 0.02% of AlphaCore Capital's portfolio in Q2 2026, its #420 holding.
  • AlphaCore Capital first reported a position in MetLife in Q1 2020 and has held it in 10 quarters since.
  • 1,440 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.